Glaukos (GKOS) Competitors $103.50 -0.13 (-0.13%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$103.42 -0.08 (-0.07%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GKOS vs. PHG, ZBH, SNN, SOLV, PEN, STVN, IRTC, NARI, TMDX, and BLCOShould you be buying Glaukos stock or one of its competitors? The main competitors of Glaukos include Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), and Bausch + Lomb (BLCO). These companies are all part of the "medical equipment" industry. Glaukos vs. Its Competitors Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Solventum Penumbra Stevanato Group iRhythm Technologies Inari Medical TransMedics Group Bausch + Lomb Koninklijke Philips (NYSE:PHG) and Glaukos (NYSE:GKOS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership. Is PHG or GKOS more profitable? Koninklijke Philips has a net margin of 2.11% compared to Glaukos' net margin of -31.40%. Koninklijke Philips' return on equity of 10.97% beat Glaukos' return on equity.Company Net Margins Return on Equity Return on Assets Koninklijke Philips2.11% 10.97% 4.57% Glaukos -31.40%-10.66%-8.06% Which has stronger valuation & earnings, PHG or GKOS? Glaukos has lower revenue, but higher earnings than Koninklijke Philips. Glaukos is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKoninklijke Philips$19.50B1.19-$758.55M$0.4356.21Glaukos$383.48M15.42-$146.37M-$2.37-43.67 Which has more risk & volatility, PHG or GKOS? Koninklijke Philips has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, Glaukos has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Does the media refer more to PHG or GKOS? In the previous week, Glaukos had 1 more articles in the media than Koninklijke Philips. MarketBeat recorded 5 mentions for Glaukos and 4 mentions for Koninklijke Philips. Glaukos' average media sentiment score of 0.87 beat Koninklijke Philips' score of 0.57 indicating that Glaukos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Glaukos 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate PHG or GKOS? Glaukos has a consensus price target of $134.67, suggesting a potential upside of 30.11%. Given Glaukos' higher possible upside, analysts plainly believe Glaukos is more favorable than Koninklijke Philips.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Glaukos 1 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do institutionals & insiders hold more shares of PHG or GKOS? 13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 99.0% of Glaukos shares are held by institutional investors. 5.8% of Glaukos shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryGlaukos beats Koninklijke Philips on 9 of the 17 factors compared between the two stocks. Get Glaukos News Delivered to You Automatically Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GKOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GKOS vs. The Competition Export to ExcelMetricGlaukosMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$5.92B$6.92B$5.54B$20.55BDividend YieldN/A1.23%5.38%3.75%P/E Ratio-43.6726.6327.4028.05Price / Sales15.4299.70420.6245.87Price / CashN/A20.9736.6322.31Price / Book7.444.748.084.59Net Income-$146.37M$173.18M$3.16B$985.44M7 Day Performance2.00%1.33%2.84%2.78%1 Month Performance13.75%-0.41%3.70%5.40%1 Year Performance-13.24%28.42%35.30%14.61% Glaukos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GKOSGlaukos4.453 of 5 stars$103.50-0.1%$134.67+30.1%-13.1%$5.92B$383.48M-43.67780PHGKoninklijke Philips3.4866 of 5 stars$22.67+1.7%N/A-7.1%$21.83B$19.50B52.7266,678ZBHZimmer Biomet4.9047 of 5 stars$91.51+0.3%$111.53+21.9%-12.1%$18.11B$7.68B20.2517,000SNNSmith & Nephew SNATS3.6949 of 5 stars$29.17+1.2%$28.00-4.0%+20.4%$12.77B$5.81B13.5017,349Positive NewsSOLVSolventum0.9595 of 5 stars$73.21-0.5%$80.29+9.7%+53.2%$12.67B$8.31B33.8922,000Positive NewsAnalyst UpgradePENPenumbra4.7389 of 5 stars$254.41-1.0%$302.40+18.9%+41.2%$9.85B$1.19B240.014,500Positive NewsInsider TradeSTVNStevanato Group1.0539 of 5 stars€23.62+1.4%N/A+36.8%€7.15B€1.19B46.315,521Positive NewsAnalyst ForecastGap DownIRTCiRhythm Technologies1.2147 of 5 stars$150.95+3.6%$138.60-8.2%+47.1%$4.82B$591.84M-48.072,000Insider TradeNARIInari Medical0.5358 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.6051 of 5 stars$127.53+3.2%$127.33-0.2%-13.9%$4.31B$441.54M93.77210Positive NewsBLCOBausch + Lomb3.3959 of 5 stars$12.01+2.3%$15.54+29.5%-5.7%$4.25B$4.79B-11.6613,500 Related Companies and Tools Related Companies PHG Alternatives ZBH Alternatives SNN Alternatives SOLV Alternatives PEN Alternatives STVN Alternatives IRTC Alternatives NARI Alternatives TMDX Alternatives BLCO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GKOS) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glaukos Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Glaukos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GKOS Stock Alerts